-
Chinese COPD innovative medicine! AstraZeneca's innovative triple inhaler budigor is officially launched for COPD maintenance treatment!
Time of Update: 2020-01-13
January 13, 2020 / BIOON / -- AstraZeneca recently announced that the triple new drug budigor inhaled aerosol of copf was officially launched in China Budesonide inhaled aerosol adopts innovative co s
-
Nat Microbiol: scientists identify the function of new microRNAs in the process of pathogenic bacteria infection
Time of Update: 2020-01-12
January 12, 2020 / BIOON/ --MicroRNAs are small RNA molecules that do not encode proteins, but they play a variety of important roles, such as acting as regulators of gene expression Therefore, microR
-
Cell: a new generation of immunosuppressive checkpoint inhibitors is on the way
Time of Update: 2020-01-12
January 12, 2020 news / BIOON / - -- three conventional methods for cancer treatment are surgical removal, radiotherapy and chemotherapy In recent years, cancer immunotherapy, such as immunocheckpoint
-
SCI adv: a new therapeutic candidate antibody is expected to treat autoimmune diseases thoroughly
Time of Update: 2020-01-12
January 12, 2020 news / BIOON / -- multiple autoimmune Sexual diseases often involve the production of pathogenic immunoglobulin G (IgG) antibodies, which can attack cells and tissues and interact wit
-
Extremely rare bone disease! Regenerating element garetosmab in the treatment of progressive ossifying fibrous dysplasia (FOP) phase II clinical success!
Time of Update: 2020-01-12
January 12, 2020 / BIOON / -- regeneron recently announced the positive results of phase II lumina-1 study on the treatment of progressive ossifying fibrodysplasia (FOP) with garetosmab (regn 2477) Ba
-
Scientists found that serum amyloid A promotes the development of inflammatory diseases
Time of Update: 2020-01-10
Recently, researchers from the Medical College of New York University and other research institutions published an article entitled "serum amyloid A proteins induce pathogenic Th17 cells and promote i
-
Nat commun: single dose antibody therapy may block the infection and replication of neonatal HIV
Time of Update: 2020-01-10
January 10, 2020 / Biovalley / recently, a research report published in the international journal Nature communications, scientists from the University of health and science of Oregon found for the fi
-
New drugs for rare diseases! Apellis C3 inhibitor pegcetacoplan head to head phase III study beat alexion C5 inhibitor soliris
Time of Update: 2020-01-09
January 9, 2020 / bioun / -- apellis Pharmaceutical Co., Ltd is committed to developing the first and best of its kind therapies through the pioneering targeting C3 method, which are used to treat a w
-
Nat Immunol: scientists are expected to develop new therapies for autoimmune diseases
Time of Update: 2020-01-09
January 9, 2020 / biool / -- recently, in a research report published in the international journal Nature Immunology, scientists from Cincinnati Children's medical center and other institutions descri
-
PNAs: combination of three antibodies can significantly improve cancer immunotherapy
Time of Update: 2020-01-09
January 9, 2020 / Biovalley BIOON / - -- in a new study, researchers from the University of Basel, Switzerland, found that the simultaneous use of antibodies with two different mechanisms of action ca
-
Rheumatoid arthritis (RA) weight new drug! Rinvoq, an oral Jak1 inhibitor, is the third regulatory approval in the world, with an annual sales volume of $2.6 billion
Time of Update: 2020-01-09
January 9, 2020 / BIOON / -- American biopharmaceutical giant abbvie recently announced that Health Canada has approved rinvoq (upadacitinib), a Jak1 inhibitor, for the treatment of adult patients wit
-
Scientists have found new drug targets for antiviral infection
Time of Update: 2020-01-09
Center for excellence and innovation of molecular cell science, Chinese Academy of Sciences (Biochemistry and cell biology Wang Hongyan's research group and Weibin (former researcher of Wuhan Virus Re
-
PNAs: scientists are expected to develop a new drug therapy for Clostridium difficile infection
Time of Update: 2020-01-09
January 9, 2020 / BIOON / -- recently, in a research report published in the international journal Proceedings of the National Academy of Sciences, scientists from New York City University and other i
-
PNAs: extremely active FoxA1 signal or reprogrammable endocrine resistant breast cancer makes it more aggressive
Time of Update: 2020-01-09
January 9, 2020 / bioun / -- recently, in a research report published in the international journal Proceedings of the National Academy of Sciences, scientists from Baylor medical college found a new m
-
Immunity: how can immune cells turn on "attack" mode?
Time of Update: 2020-01-09
January 9, 2020 / BIOON / -- recently, an international magazine, immunology In the previous research report, scientists from Bonn University found that macrophages often have two sides In healthy tis
-
Cell: new tools are expected to accelerate antibody recognition and vaccine development and research, or to benefit multiple diseases such as HIV
Time of Update: 2020-01-06
January 6, 2020 / bioun / -- recently, in a research report published in the international journal Cell, scientists from Vanderbilt University have developed a new tool or are expected to accelerate t
-
NEJM: new drugs are expected to treat patients with malignant breast cancer
Time of Update: 2020-01-06
January 6, 2020 / BIOON / - recently, in a research report published in the International Journal New England Journal of medicine, scientists from Dana Farber Cancer Research Institute and other insti
-
Jak1 inhibitor! The first-line treatment of acute graft-versus-host disease (aGVHD) with incite itacitinib, a partner of Cinda biology, failed in critical phase III!
Time of Update: 2020-01-06
January 6, 2020 / BIOON / - Cinda biological partner Incyte company recently announced the results of the critical phase III gravitas-301 study (nct03139604) on the first-line treatment of acute graft
-
NEJM: a targeted combination therapy may make postmenopausal patients with malignant breast cancer live longer!
Time of Update: 2020-01-06
January 6, 2020 / Biovalley / recently, a research report published in the International Journal New England Journal of medicine, scientists from the University of California found that adding targete
-
It is found that the evolution of human immune system has "side effects"
Time of Update: 2020-01-05
The human immune system has been evolving, which can help us better resist some diseases, but also has some "side effects" Changes in DNA fragments associated with the evolution of the immune system m
